Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma.

Liberatore C, Perini T, Passeri C, Ferla V, Fioritoni F, Girlando V, Iuliani O, Orsini A, Montanaro G, Farina F, Di Nicola A, Nitti R, Pulini S, Mastaglio S, Santarone S, Coppola M, Marktel S, Accorsi P, Ciceri F, Marcatti M, Di Ianni M

Open source

DOI: 10.3324/haematol.2023.283452
Published: 2023 Dec 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2023.283452,
  title = {Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma.},
  author = {Liberatore C and Perini T and Passeri C and Ferla V and Fioritoni F and Girlando V and Iuliani O and Orsini A and Montanaro G and Farina F and Di Nicola A and Nitti R and Pulini S and Mastaglio S and Santarone S and Coppola M and Marktel S and Accorsi P and Ciceri F and Marcatti M and Di Ianni M},
  year = {2023},
  journal = {Haematologica},
  doi = {10.3324/haematol.2023.283452},
  url = {https://doi.org/10.3324/haematol.2023.283452}
}

RIS

TY  - JOUR
TI  - Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma.
AU  - Liberatore C
AU  - Perini T
AU  - Passeri C
AU  - Ferla V
AU  - Fioritoni F
AU  - Girlando V
AU  - Iuliani O
AU  - Orsini A
AU  - Montanaro G
AU  - Farina F
AU  - Di Nicola A
AU  - Nitti R
AU  - Pulini S
AU  - Mastaglio S
AU  - Santarone S
AU  - Coppola M
AU  - Marktel S
AU  - Accorsi P
AU  - Ciceri F
AU  - Marcatti M
AU  - Di Ianni M
PY  - 2023
JO  - Haematologica
DO  - 10.3324/haematol.2023.283452
UR  - https://doi.org/10.3324/haematol.2023.283452
ER  -

APA

C, L., T, P., C, P., V, F., F, F., V, G., O, I., A, O., G, M., F, F., A, D. N., R, N., S, P., S, M., S, S., M, C., S, M., P, A., F, C., M, M., & M, D. I. (2023). Higher cyclophosphamide dose grants optimal stem cell collection after daratumumab-based induction in multiple myeloma.. Haematologica. https://doi.org/10.3324/haematol.2023.283452

Source records

pubmed · retrieved 2026-09-26T13:53:07.270Z